{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:39:52Z","timestamp":1784644792218,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["JUST\/2013\/ISEC\/DRUGS\/AG\/6421"],"award-info":[{"award-number":["JUST\/2013\/ISEC\/DRUGS\/AG\/6421"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.forsciint.2017.10.042","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T04:30:30Z","timestamp":1510115430000},"page":"e9-e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"special_numbering":"C","title":["Three fatalities associated with the synthetic cannabinoids 5F-ADB, 5F-PB-22, and AB-CHMINACA"],"prefix":"10.1016","volume":"281","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3081-4609","authenticated-orcid":false,"given":"V.","family":"Angerer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jacobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Franz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1883-2804","authenticated-orcid":false,"given":"V.","family":"Auw\u00e4rter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Pietsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2017.10.042_bib0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.forsciint.2013.08.023","article-title":"Escalation of methamphetamine-related crime and fatalities in the Dresden region, Germany, between 2005 and 2011","volume":"233","author":"Pietsch","year":"2013","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2017.10.042_bib0010","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/jms.1811","article-title":"Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds","volume":"45","author":"Dresen","year":"2010","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.forsciint.2017.10.042_bib0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00414-013-0864-1","article-title":"Driving under the influence of synthetic cannabinoids (Spice): a case series","volume":"128","author":"Musshoff","year":"2013","journal-title":"Int. J. Leg. Med."},{"key":"10.1016\/j.forsciint.2017.10.042_bib0020","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1360-0443.2012.04078.x","article-title":"Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings","volume":"108","author":"Hermanns-Clausen","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.forsciint.2017.10.042_bib0025","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/jms.1558","article-title":"\u2018Spice\u2019 and other herbal blends: harmless incense or cannabinoid designer drugs?","volume":"44","author":"Auw\u00e4rter","year":"2009","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.forsciint.2017.10.042_bib0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.forsciint.2009.06.008","article-title":"Spice: a never ending story?","volume":"191","author":"Lindigkeit","year":"2009","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2017.10.042_bib0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.toxlet.2010.06.002","article-title":"Spice drugs as a new trend: mode of action, identification and legislation","volume":"197","author":"Vardakou","year":"2010","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.forsciint.2017.10.042_bib0040","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.chroma.2012.12.049","article-title":"New challenges and innovation in forensic toxicology. Focus on the new psychoactive substances","volume":"1287","author":"Favretto","year":"2013","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.forsciint.2017.10.042_bib0045","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.pnpbp.2012.04.017","article-title":"Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids","volume":"39","author":"Seely","year":"2012","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.forsciint.2017.10.042_bib0050","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00204-013-1029-1","article-title":"Toxicological profiles of selected synthetic cannabinoids showing high binding affinities to the cannabinoid receptor subtype CB1","volume":"87","author":"Koller","year":"2013","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.forsciint.2017.10.042_bib0055","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/jms.3020","article-title":"Analysis of 30 synthetic cannabinoids in serum by liquid chromatography\u2013electrospray ionization tandem mass spectrometry after liquid\u2013liquid extraction","volume":"47","author":"Kneisel","year":"2012","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.forsciint.2017.10.042_bib0060","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/jat\/bks048","article-title":"Detection and quantification of new designer drugs in human blood: part 1\u2014synthetic cannabinoids","volume":"36","author":"Ammann","year":"2012","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2017.10.042_bib0065","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/FBP.0000000000000150","article-title":"Delta9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market","volume":"26","author":"Gatch","year":"2015","journal-title":"Behav. Pharmacol."},{"issue":"7","key":"10.1016\/j.forsciint.2017.10.042_bib0070","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1021\/cn400035r","article-title":"The synthesis and pharmacological evaluation of adamantane-derived indoles: novel cannabimimetic drugs of abuse","volume":"4","author":"Banister","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.forsciint.2017.10.042_bib0075","unstructured":"EMCDDA reporting form on the new drug 5F-ADB, Forensic Toxicology Department University Medical Center Freiburg, 2015, accessible via EDND database of the EMCDDA."},{"issue":"9","key":"10.1016\/j.forsciint.2017.10.042_bib0080","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1021\/acschemneuro.5b00112","article-title":"Pharmacology of valinate and tert-leucinate synthetic cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and their analogues","volume":"6","author":"Banister","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.forsciint.2017.10.042_bib0085","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3109\/15563650.2015.1100306","article-title":"An outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACA","volume":"53","author":"Tyndall","year":"2015","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.forsciint.2017.10.042_bib0090","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/jat\/bkv091","article-title":"Concentrations of AB-CHMINACA and AB-PINACA and driving behavior in suspected impaired driving cases","volume":"39","author":"Peterson","year":"2015","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2017.10.042_bib0095","article-title":"Validated LC\u2013MS\/MS method for qualitative and quantitative analysis of 75 synthetic cannabinoids in serum","author":"Angerer","year":"2015","journal-title":"53rd Annual meeting of the International Association of Forensic Toxicologists (TIAFT)"},{"key":"10.1016\/j.forsciint.2017.10.042_bib0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/jms.3328","article-title":"A comprehensive library-based, automated screening procedure for 46 synthetic cannabinoids in serum employing liquid chromatography-quadrupole ion trap mass spectrometry with high-temperature electrospray ionization","volume":"49","author":"Huppertz","year":"2014","journal-title":"J. Mass Spectrom."},{"issue":"3","key":"10.1016\/j.forsciint.2017.10.042_bib0105","first-page":"185","article-title":"Appendix B of the GTFCh guidelines for quality assurance in forensic-toxicological analyses: requirements for the validation of analytical methods","volume":"76","author":"Peters","year":"2009","journal-title":"Toxichem Krimtech"},{"key":"10.1016\/j.forsciint.2017.10.042_bib0110","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/jms.3229","article-title":"Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism","volume":"48","author":"Hutter","year":"2013","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.forsciint.2017.10.042_bib0115","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11419-014-0247-4","article-title":"Inhomogeneities in herbal mixtures: a serious risk for consumers","volume":"33","author":"Moosmann","year":"2015","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.forsciint.2017.10.042_bib0120","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/jms.3328","article-title":"A comprehensive library-based, automated screening procedure for 46 synthetic cannabinoids in serum employing liquid chromatography-quadrupole ion trap mass spectrometry with high-temperature electrospray ionization","volume":"49","author":"Huppertz","year":"2014","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.forsciint.2017.10.042_bib0125","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/jat\/bku048","article-title":"Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22","volume":"38","author":"Behonick","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2017.10.042_bib0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11419-014-0245-6","article-title":"Postmortem distribution of AB-CHMINACA, 5-fluoro-AMB, and diphenidine in body fluids and solid tissues in a fatal poisoning case: usefulness of adipose tissue for detection of the drugs in unchanged forms","volume":"33","author":"Hasegawa","year":"2015","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.forsciint.2017.10.042_bib0135","first-page":"482","article-title":"Fatal poisoning with the synthetic cannabinoid AB-CHMINACA and ethyl alcohol\u2014a case study and literature review","volume":"106","author":"Gieron","year":"2016","journal-title":"Probl. Forensic Sci."},{"key":"10.1016\/j.forsciint.2017.10.042_bib0140","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.forsciint.2015.08.012","article-title":"Death due to diabetic ketoacidosis: induction by the consumption of synthetic cannabinoids","volume":"257","author":"Hess","year":"2015","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2017.10.042_bib0145","first-page":"86","article-title":"Sudden cardiac death following use of the synthetic cannabinoid MDMB-CHMICA","volume":"40","author":"Westin","year":"2016","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2017.10.042_bib0150","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jat\/bkw004","article-title":"Reply to \u2018sudden cardiac death following use of the synthetic cannabinoid MDMB-CHMICA\u2019","volume":"40","author":"Angerer","year":"2016","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2017.10.042_bib0155","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.forsciint.2016.05.031","article-title":"Separation and structural characterization of the new synthetic cannabinoid JWH-018 cyclohexyl methyl derivative \u2018NE-CHMIMO\u2019 using flash chromatography, GC\u2013MS, IR and NMR spectroscopy","volume":"266","author":"Angerer","year":"2016","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2017.10.042_bib0160","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11419-014-0259-0","article-title":"Identification and quantitation of 5-fluoro-ADB, one of the most dangerous synthetic cannabinoids, in the stomach contents and solid tissues of a human cadaver and in some herbal products","volume":"33","author":"Hasegawa","year":"2014","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.forsciint.2017.10.042_bib0165","article-title":"Fatal intoxication by 5F-ADB and diphenidine: detection, quantification, and investigation of their main metabolic pathways in human by LC\/MS\/MS and LC\/Q-TOFMS","author":"Kusano","year":"2017","journal-title":"Drug Test. Anal."},{"issue":"4","key":"10.1016\/j.forsciint.2017.10.042_bib0170","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/jat\/bkw013","article-title":"To measure or not to measure? That is the NPS question","volume":"40","author":"Gerostamoulos","year":"2016","journal-title":"J. Anal. Toxicol."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037907381730453X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037907381730453X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T07:59:52Z","timestamp":1690963192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037907381730453X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":34,"alternative-id":["S037907381730453X"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2017.10.042","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three fatalities associated with the synthetic cannabinoids 5F-ADB, 5F-PB-22, and AB-CHMINACA","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2017.10.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}